UB Paderborn / Katalog / Suche / in CDI

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

The Journal of clinical investigation, 2005-12, Vol.115 (12), p.3623-3633

2005

Link zum Volltext

Verfügbarkeit prüfen

Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer

Cancer research (Chicago, Ill.), 2000-10, Vol.60 (19), p.5522-5528

2000

Link zum Volltext

Verfügbarkeit prüfen

Specific binding of HIV‐1 nucleocapsid protein to PSI RNA in vitro requires N‐terminal zinc finger and flanking basic amino acid residues

The EMBO journal, 1994-04, Vol.13 (7), p.1525-1533

1994

Link zum Volltext

Verfügbarkeit prüfen

Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer

The Journal of immunology (1950), 2005-03, Vol.174 (6), p.3798-3807

2005

Link zum Volltext

Verfügbarkeit prüfen

Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells

Cancer research (Chicago, Ill.), 2003-05, Vol.63 (9), p.2127-2133

2003

Link zum Volltext

Verfügbarkeit prüfen

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

The Journal of clinical investigation, 2002-02, Vol.109 (3), p.409-417

2002

Link zum Volltext

Verfügbarkeit prüfen

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

The Journal of clinical investigation, 2002-02, Vol.109 (3), p.409-417

2002

Link zum Volltext

Verfügbarkeit prüfen

Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro

Journal of Virology, 1996-02, Vol.70 (2), p.771-777

1996

Link zum Volltext

Verfügbarkeit prüfen

Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo Maturation

The Journal of immunology (1950), 2003-12, Vol.171 (11), p.6275-6282

2003

Link zum Volltext

Verfügbarkeit prüfen

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

Vaccine, 2003-03, Vol.21 (11), p.1250-1255

2003

Link zum Volltext

Verfügbarkeit prüfen

Enhanced induction of telomerase-specific CD4+ T cells using dendritic cells transfected with RNA encoding a chimeric gene product

Cancer research (Chicago, Ill.), 2002-09, Vol.62 (17), p.5041-5048

2002

Link zum Volltext

Verfügbarkeit prüfen

Induction of Human Dendritic Cell Maturation Using Transfection with RNA Encoding a Dominant Positive Toll-Like Receptor 4

The Journal of immunology (1950), 2004-06, Vol.172 (11), p.7162-7168

2004

Link zum Volltext

Verfügbarkeit prüfen

Technology Insight: vaccine therapy for prostate cancer

Nature clinical practice urology, 2005-01, Vol.2 (1), p.44-51

2005

Link zum Volltext

Verfügbarkeit prüfen

The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides

Biochimie, 1993, Vol.75 (1), p.71-78

1993

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of antitumor immunity following depletion of CD4 + CD25 + regulatory T cells

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2506-2506

2004

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of antitumor immunity following depletion of CD4 + CD25 + regulatory T cells

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2506-2506

2004

Link zum Volltext

Verfügbarkeit prüfen

Reversal of immature myeloid cell-mediated immunosuppression

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.2563-2563

2005

Link zum Volltext

Verfügbarkeit prüfen

Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen

Cancer research (Chicago, Ill.), 1997-02, Vol.57 (3), p.495-499

1997

Link zum Volltext

Verfügbarkeit prüfen

Development of gene therapy for prostate cancer using a novel promoter of prostate‐specific antigen

British Journal of Urology, 1997-03, Vol.79 (S1), p.97-103

1997

Link zum Volltext

Verfügbarkeit prüfen

Tumor vaccines: from gene therapy to dendritic cells—the emerging frontier

Urologic Clinics of North America, 2003-08, Vol.30 (3), p.633-643

2003

Link zum Volltext

Verfügbarkeit prüfen

Immature myeloid cell (ImC)- mediated immunosuppression in advanced renal cell cancer (RCC)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10042-10042

2006

Link zum Volltext

Verfügbarkeit prüfen

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results from a phase I clinical trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2507-2507

2004

Link zum Volltext

Verfügbarkeit prüfen

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results from a phase I clinical trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2507-2507

2004

Link zum Volltext

Verfügbarkeit prüfen

Cotransfection of DC with TLR4 and MART-1 RNA induces MART-1-specific responses

The Journal of surgical research, 2005-04, Vol.124 (2), p.264-273

2005

Link zum Volltext

Verfügbarkeit prüfen

Conformational and Nucleic Acid Binding Studies on the Synthetic Nucleocapsid Protein of HIV-1

Journal of molecular biology, 1993-01, Vol.229 (1), p.94-104

1993

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer

Specific binding of HIV‐1 nucleocapsid protein to PSI RNA in vitro requires N‐terminal zinc finger and flanking basic amino acid residues

Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer

Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro

Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo Maturation

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

Enhanced induction of telomerase-specific CD4+ T cells using dendritic cells transfected with RNA encoding a chimeric gene product

Induction of Human Dendritic Cell Maturation Using Transfection with RNA Encoding a Dominant Positive Toll-Like Receptor 4

Technology Insight: vaccine therapy for prostate cancer

The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides

Enhancement of antitumor immunity following depletion of CD4 + CD25 + regulatory T cells

Enhancement of antitumor immunity following depletion of CD4 + CD25 + regulatory T cells

Reversal of immature myeloid cell-mediated immunosuppression

Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen

Development of gene therapy for prostate cancer using a novel promoter of prostate‐specific antigen

Tumor vaccines: from gene therapy to dendritic cells—the emerging frontier

Immature myeloid cell (ImC)- mediated immunosuppression in advanced renal cell cancer (RCC)

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results from a phase I clinical trial

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results from a phase I clinical trial

Cotransfection of DC with TLR4 and MART-1 RNA induces MART-1-specific responses

Conformational and Nucleic Acid Binding Studies on the Synthetic Nucleocapsid Protein of HIV-1

Suchergebnisse filtern